Leading Kidney Care Platform

Debt Maturity Schedule Credit Agreement and Bond Debt outstanding, $ in millions Term Loan A Revolver1 Term Loan B 9/30/21 LTM Consolidated EBITDA2 $2,558 $2,384 4.625% Sr. Notes 3.750% Sr. Notes $2,579 $2,750 $1,500 $29 $126 $170 $27 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 Note: Excludes other debt and deferred financing cost 1) 2) $1,000 revolver expires in 2024 Consolidated EBITDA as defined per Credit Agreement, which is a non-GAAP measure. See appendix for reconciliation of this non-GAAP measure to the most comparable GAAP measure 58 © 2021 DaVita Inc. All rights reserved. *

View entire presentation